Zinger Key Points
- Summit Therapeutics stock declined after announcing topline results from its Phase 3 HARMONi trial.
- Regeneron Pharmaceutical shares fell after mixed results from its AERIFY-1 and AERIFY-2 studies for smoker's lung disease.
- Ready to turn the market’s comeback into steady cash flow? Grab the top 3 stocks to buy right here.
These eleven large-cap stocks were the worst performers in the last week. Are they in your portfolio?
- Summit Therapeutics Inc.’s SMMT stock declined 29.32% after the company announced topline results from its Phase 3 HARMONi trial.
- Temu parent PDD Holdings Inc. PDD shares tumbled 19.44% after President Trump said China had violated its agreement with the U.S. Additionally, a federal appeals court on Thursday temporarily reinstated most of the tariffs imposed by Trump.
- Regeneron Pharmaceuticals, Inc. REGN shares fell 17.86% after the company and Sanofi said the AERIFY-1 study met its primary endpoint, but the AERIFY-2 study did not.
- Booz Allen Hamilton BAH dipped 17.72% after Barclays maintained an Equal-Weight rating on the stock and lowered its price forecast from $140 to $120.
- Okta, Inc. OKTA stock declined 16.74% after the company reported first-quarter financial results and provided cautious forward-looking commentary. Multiple analysts also lowered price forecasts following the report.
- Deckers Outdoor Corporation DECK shares were down 16.31%, possibly amid overall market strength, after President Trump had delayed 50% EU tariffs until July.
- Copart, Inc. CPRT dipped 15.13% last week. The stock continued its decline after reporting a third-quarter revenue miss.
- The Cooper Companies, Inc. COO shares decreased 13.90% despite a second-quarter earnings beat. JP Morgan downgraded the stock from Overweight to Neutral and lowered its price forecast from $110 to $76.
- Texas Pacific Land Corporation TPL stock fell 12.89%.
- HP Inc. HPQ stock was down 12.63% after it reported mixed second-quarter earnings and cut its outlook. Additionally, several firms cut their respective price forecasts on the stock.
- Burlington Stores, Inc. BURL stock declined 11.90% after its first-quarter results. Additionally, several firms revised their respective price forecasts on the stock.
Image Via Shutterstock
Loading...
Loading...
BURLBurlington Stores Inc
$237.832.13%
Edge Rankings
Momentum
31.30
Growth
97.38
Quality
46.71
Value
47.36
Price Trend
Short
Medium
Long
PDDPDD Holdings Inc
$98.542.18%
REGNRegeneron Pharmaceuticals Inc
$488.78-0.41%
BAHBooz Allen Hamilton Holding Corp
$104.921.56%
COOThe Cooper Companies Inc
$66.77-0.34%
CPRTCopart Inc
$51.351.08%
DECKDeckers Outdoor Corp
$105.750.70%
HPQHP Inc
$25.381.89%
OKTAOkta Inc
$103.32-1.35%
SMMTSummit Therapeutics Inc
$20.4615.4%
TPLTexas Pacific Land Corp
$1126.371.46%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in